Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia

Clinical trial NCT06973356 · RECRUITING

Trial details

NCT number: NCT06973356
Sponsor: Anhui Provincial Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Immune Thrombocytopenia (ITP)

Start date: 2025-08-16
Primary completion: 2029-06-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.